These signs of frostbite will let you know how severely the cold is affecting you. Rachel Schoutsen and Kyle Brittain explain.
These signs of frostbite will let you know how severely the cold is affecting you. Rachel Schoutsen and Kyle Brittain explain.
(Cecilia Fabiano/LaPresse/The Associated Press - image credit) Health Canada's approval of the Oxford-AstraZeneca and the Serum Institute of India's version to prevent COVID-19 in adults follows similar green lights from regulators in the United Kingdom, Europe Union, Mexico and India. The Oxford-AstraZeneca vaccine, called ChAdOx1, was approved for use in Canada on Friday following clinical trials in the United Kingdom and Brazil that showed a 62.1 per cent efficacy in reducing symptomatic cases of COVID-19 cases among those given the vaccine. Experts have said any vaccine with an efficacy rate of over 50 per cent could help stop outbreaks. Dr. Supriya Sharma, Health Canada's chief medical adviser, said the key number across all of the clinical trials for those who received AstraZeneca's product was zero — no deaths, no hospitalizations for serious COVID-19 and no deaths because of an adverse effect of the vaccine. "I think Canada is hungry for vaccines," Sharma said in a briefing. "We're putting more on the buffet table to be used." Specifically, 64 of 5,258 in the vaccination group got COVID-19 with symptoms compared with people in the control group given injections (154 of 5,210 got COVID-19 with symptoms). Dr. Susy Hota, medical director of infection prevention and control at Toronto's University Health Network, called it a positive move to have AstraZeneca's vaccines added to Canada's options. "Even though the final efficacy of the AstraZeneca vaccine appears lower than what we have with the mRNA vaccines, it's still reasonably good," Hota said. "What we need to be focusing on is trying to get as many people as possible vaccinated so we can prevent the harms from this." Canada has an agreement with AstraZeneca to buy 20 million doses as well as between 1.9 million and 3.2 million doses through the global vaccine-sharing initiative known as COVAX. WATCH | AstraZeneca vaccine safety: Canada will also receive 2 million doses of AstraZeneca's COVID-19 vaccine manufactured by the Serum Institute of India, the government announced Friday. Here's a look at some common questions about the vaccine, how it works, in whom and how it could be rolled out. What's different about this shot? The Oxford-AstraZeneca is cheaper and easier to handle than the mRNA vaccines from Pfizer-BioNTech and Moderna, which need to be stored at ultracold temperatures to protect the fragile genetic material. AstraZeneca says its vaccine can be stored, transported and handled at normal refrigerated conditions (2 to 8 C) for at least six months. (Moderna's product can be stored at refrigeration temperatures for 30 days after thawing.) The ease of handling could make it easier to administer AstraZeneca's vaccine in rural and remote areas of Canada and the world. "There are definitely some advantages to having multiple vaccine candidates available to get to as many Canadians as possible," Hota said. Sharma said while the product monograph notes that evidence for people over age 65 is limited, real-world data from countries already using AstraZeneca's vaccine suggest it is safe and effective among older age groups. "We have real-world evidence from Scotland and the U.K. for people that have been dosed that would have been over 80 and that has shown significant drop in hospitalizations to the tune of 84 per cent," Sharma said. Data from clinical trials is more limited compared with in real-world settings that reflect people from different age groups, medical conditions and other factors. How does it work? Vaccines work by training our immune system to recognize an invader. The first two vaccines to protect against COVID-19 that were approved for use in Canada deliver RNA that encodes the spike protein on the surface of the pandemic coronavirus. Health-care workers Diego Feitosa Ferreira, right, and Clemilton Lopes de Oliveira travel on a boat in the state of Amazonas in Brazil, on Feb. 12, to vaccinate residents with the Oxford-AstraZeneca COVID-19 vaccine. The product can be stored at refrigeration temperatures, which facilitates its use in remote areas. In contrast, the AstraZeneca vaccine packs the genetic information for the spike protein in the shell of a virus that causes the common cold in chimpanzees. Vaccine makers altered the adenovirus so it can't grow in humans. Viral vector vaccines mimic viral infection more closely than some other kinds of vaccines. One disadvantage of viral vectors is that if a person has immunity toward a particular vector, the vaccine won't work as well. But people are unlikely to have been exposed to a chimpanzee adenovirus. How and where could it be used? Virologist Eric Arts at Western University in London, Ont., said vaccines from Oxford-AstraZeneca, Johnson & Johnson, which is also under review by Health Canada, and Russian Sputnik-V vaccines all have some similarities. "I do like the fact that AstraZeneca has decided to continue trials, to work with the Russians on the Sputnik-V vaccine combination," said Arts, who holds the Canada Research Chair in HIV pathogenesis and viral control. Boxes with AstraZeneca's COVID-19 vaccine are pictured at St. Mary's Hospital in Dublin, Ireland. Health Canada says the vaccine is given by two separate injections of 0.5 millilitres each into the muscle of the arm. "The reason why I'm encouraged by it is I think there might be greater opportunity to administer those vaccines in low- to middle-income countries. We need that. I think our high-income countries have somewhat ignored the situation that is more significant globally." Researchers reported on Feb. 2 in the journal Lancet that in a Phase 3 clinical trial involving about 20,000 people in Russia, the two-dose Sputnik-V vaccine was about 91 per cent effective and appears to prevent inoculated individuals from becoming severely ill with COVID-19. There were 16 COVID-19 cases in the vaccine group (0.1 per cent or 16/14,964) and 62 cases (1.3 per cent or [62/4,902 ) in the control group. No serious adverse events were associated with vaccination. Most adverse events were mild, such as flu-like symptoms, pain at injection site and weakness or low energy. An analysis of results from 2,000 adults older than 60 years suggested the vaccine was similarly effective and well tolerated in this age group. Arts and other scientists acknowledged the speed and lack of transparency of the Russian vaccination program. But British scientists Ian Jones and Polly Roy wrote in an accompanying commentary that the results are clear and add another vaccine option to reduce the incidence of COVID-19.
Giorgio Armani is taking fashionistas back to the 1980s for his fall Emporio Armani line, nodding to the era's bright colours in his latest creations at Milan Fashion Week. The veteran designer, affectionately called "King Giorgio" in his native Italy, presented plenty of hot pink and purple creations, high-waisted trousers and chunky jewellery in the autumn/winter 2021-2022 collection called "In the mood for pop". In a video presented at the virtual Milan Fashion Week on Thursday, models wore wide-leg trousers with suspenders, velvet jumpsuits and round-shouldered jackets and coats, some with boule buttons, others with shiny patterns.
India's National Stock Exchange on Friday defended its reopening the market after an unexpected shutdown this week, amid criticism about how it handled the situation. Brokers had criticised the NSE over the lack of information after the four-hour shutdown on Wednesday. India's largest stock exchange, NSE announced on Wednesday it shut at 11:40 a.m. local time because of a telecoms problem.
Hamilton police say they have arrested a man and woman after finding the body of a dead baby. Police say they were called early Wednesday morning with a tip about "suspicious circumstances" at a home. Investigators say that following that information they found a body of what appears to be a newborn child buried in the building's basement. A post-mortem examination will take place over the coming days to determine the cause of death. The 34-year-old man and 24-year-old woman were charged on Thursday with criminal negligence causing death and Interfering with a dead body. Police say they expect to be at the scene for several days. This report by The Canadian Press was first published Feb. 26, 2021. The Canadian Press
En décembre 2018, les industriels forestiers se sont engagés à augmenter les tarifs de transport de 16 % sur deux ans. Après une augmentation de près de 9 % en 2019, les camionneurs forestiers ont accepté un gel des tarifs pendant la pandémie, en raison de l’incertitude, mais ils attendent toujours la balance de l’augmentation des tarifs promise. « C’est le minimum qu’on demande pour atteindre un seuil de rentabilité acceptable », lance d’emblée Carol Girard, le représentant forêt pour l’Association nationale des camionneurs artisans inc. (ANCAI), en faisant référence à l’entente conclue en décembre 2018. À l’époque, les camionneurs avaient menacé les industriels de faire une grève d’une journée. Devant cette menace, les industriels du Saguenay-Lac-Saint-Jean avaient accepté de négocier directement avec les camionneurs, qui doivent habituellement passer par les expéditeurs et les entrepreneurs généraux en foresterie pour négocier les tarifs. Après une rencontre de trois jours, les transformateurs de bois avaient accepté une augmentation de tarifs de 15 à 16 % sur deux ans. En 2019, les tarifs ont bel et bien augmenté de 8 à 9 %, mais la pandémie est venue chambouler le reste du rattrapage. Devant l’incertitude, la plupart des industriels ont gelé les tarifs, alors que certains ont consenti à offrir une petite augmentation allant jusqu’à 1,5 %. Pour être conciliants, les camionneurs ont accepté la situation, mais l’ANCAI s’attend maintenant à recevoir la balance de l’augmentation négociée en 2018, d’autant plus que le prix du bois d’œuvre sur les marchés atteint des sommets. Selon les recherches comptables effectuées par l’ANCAI, le rattrapage de 16 % sur deux ans permettrait aux entreprises de transport de dégager un bénéfice de 8 %, explique Mario Beaulieu, lui aussi représentant forêt pour l’ANCAI. Un tel bénéfice permettrait d’amortir les dépenses surprises, comme le bris d’un moteur, qui peut coûter 40 000$. La durée des voyages dans la balance Selon les représentants de l’ANCAI, c’est au Saguenay-Lac-Saint-Jean que la situation est la plus problématique de la province, car les temps de cycle sont calculés différemment ailleurs. Le temps de cycle, c’est la durée d’un voyage d’un camionneur quand il part vide de l’usine, pour remplir un chargement en forêt et revenir à l’usine. Pour calculer le temps de cycle, il faut tenir compte des limites de vitesse et les ajuster en fonction de la vitesse réelle des camions. Selon l’ANCAI, les vitesses établies au Saguenay-Lac-Saint-Jean sont plus élevées que dans toutes les autres régions. Par exemple, dans les Laurentides ou en Abitibi, le temps de cycle est calculé en tenant compte qu’un camion pourra se déplacer, en moyenne, à 80 % de la vitesse permise, en tenant compte des arrêts et du trafic routier. Dans la région, les calculs sont plus serrés, alors que certains industriels calculent des vitesses de déplacement allant à 100 % de la vitesse permise, parfois 110 %, notent les représentants de l’ANCAI. « Ici, les temps de cycle ne sont jamais corrects, note Carol Girard. Si je dois faire un voyage en cinq heures et que ça me prend cinq heures et demie, j’ai une demi-heure qui ne sera pas payée et ça vient jouer sur mon taux horaire. » Plus les temps de cycle sont serrés et plus la pression est grande pour que les camionneurs roulent plus vite, ce qui pose un danger pour tous les utilisateurs de la route. « On voudrait que l’environnement d’affaires soit pareil pour tous », soutient Mario Beaulieu, ce qui permettrait d’éviter le marchandage et de stabiliser les équipes au même endroit. Ainsi, l’ANCAI revendique que les temps de cycle soient calculés à 80 % de la vitesse permise partout au Québec. Quelques bémols Selon les informations recueillies auprès d’acteurs forestiers qui préfèrent garder l’anonymat en cette période de négociation, les temps de cycle sont en effet très serrés, mais les tarifs sont ajustés 90 % du temps. Si le temps de cycle excède de 6,25 % le temps calculé, Produits forestiers Résolu (PFR) verse un tarif supplémentaire à l’entrepreneur. Si le temps de cycle est moindre de 6,25 %, le tarif est toutefois ajusté à la baisse. De plus, PFR calcule le temps de cycle à 80 km/h dans une zone ou la vitesse permise est de 90 km/h. Selon Carol Girard, la vitesse devrait être de 72 km/h, ce qui limiterait les empressements des chauffeurs sur les routes… tout en permettant d’être plus rentables, comme c’est le cas à l’heure actuelle en Mauricie et dans plusieurs régions. D’autres industriels n’offrent pas des ajustements de prix et ce sont parfois les expéditeurs et les entrepreneurs généraux qui doivent mettre la main dans leur poche pour compenser les transporteurs. De plus, la plupart des camionneurs chargent beaucoup plus que les 35 tonnes prévues, avec une moyenne qui avoisine davantage les 39 tonnes, voire plus, pour le bois résineux. Peu importe la formule établie, les chauffeurs doivent gagner 115$ de l’heure à la fin de la journée pour être rentables et dégager un profit décent, estime l’ANCAI. Au cours de la dernière année, les fortes pluies et le gel tardif ont grandement dégradé le réseau routier, ce qui a généré des délais supplémentaires. Il serait donc pertinent de s’assurer de bâtir davantage de chemins à l’avance pour transporter le bois dans de meilleures conditions. Questionné à ce sujet, Louis Bouchard, directeur principal, affaires publiques et relations gouvernementales chez PFR, a préféré ne pas commenter sur les tarifs, qui sont du domaine commercial. « Nos entrepreneurs sont un maillon crucial de nos activités et, en ce sens, nous maintenons avec eux un dialogue soutenu et travaillons à leur offrir des conditions reflétant cet état de fait. » Au bout du compte, les camionneurs souhaitent s’entendre sur un taux horaire juste, qui leur permettra de payer pour la maintenance et de dégager un profit pour en vivre. Ils ne sont toutefois pas les seuls à demander une augmentation des tarifs, car les entrepreneurs forestiers s’attendent aussi à avoir une hausse substantielle de leur rémunération. Guillaume Roy, Initiative de journalisme local, Le Quotidien
Fisheries and Oceans Canada (DFO) has announced a $7-million satellite program to locate and track people who are fishing illegally near Ecuador's Galapagos Islands. “Illegal fishing threatens the health of our fish stocks and takes resources away from hard-working, law-abiding fishers,” said Fisheries and Oceans Minister Bernadette Jordan in a press release. “We're investing in one of the leading, most innovative systems on the planet to ensure our fish stocks are protected, our fisheries remain lucrative, and the law is upheld at sea.” The Dark Vessel Detection program uses satellite technology to detect “dark vessels,” ones that have turned off their location transmitting devices in order to avoid being caught, according to DFO. It’s estimated that illegal, unreported and unregulated (IUU) fishing accounts for about 30 per cent of all fishing activity worldwide, representing up to 26 million tonnes of fish caught annually at a cost to the global economy of $10 billion to $23 billion a year, according to the Food and Agriculture Organization of the United Nations. DFO awarded Ontario-based space technology company MDA — the maker of the Canadarm — with a three-year contract to supply the technology for the program. It will provide data and analysis to officials in Ecuador and the Forum Fisheries Agency, which represents 15 small island nations in the Pacific region, so they can spend their resources on enforcement to protect their fish stocks, DFO says. MDA says the program will combine data from multiple satellite missions, including the Canadian Space Agency Earth observation satellite, RADARSAT-2. The Dark Vessel Detection program is part of the $11.6 million Canada committed to ocean health at the 2018 G7 meeting. DFO kicked off a smaller-scale program in June to track vessels in the Bahamas and Costa Rica, which saw “significant” fines to five foreign vessels, according to the department. Canada has been under fire for having illegal seafood in its supply chains. Oceana Canada says the country has “inadequate traceability standards” to monitor its seafood supply chain. As a result, the Canadian economy is losing up to $93.8 million in tax revenue each year due to illegal and unreported fishing, according to an Oceana Canada report released in November. Meanwhile, Canadian fishers are missing out on up to $379 million in lost revenue, per the report. The ocean conservation organization has been calling on the feds to develop a boat-to-plate traceability system that would track information about seafood products and disseminate it throughout supply chains. Prime Minister Justin Trudeau tasked Jordan and Health Minister Patty Hajdu to tackle it in their 2019 mandate letters, but no timeline for this plan has been released. This task, however, wasn’t included in Jordan’s or Hajdu’s subsequent 2021 letters. Yasmine Ghania, Local Journalism Initiative Reporter, National Observer
BEIJING — The thrills and chills of the big screen are back big-time in the world’s largest film market. With the coronavirus well under control in China and cinemas running at half capacity, moviegoers are smashing China's box office records, with domestic productions far outpacing their Hollywood competitors. February marked China’s all-time biggest month for movie ticket sales, which have so far totalled 11.2 billion yuan ($1.7 billion). China overtook the U.S. as the world’s biggest market for movie ticket sales last year as the American box office took a massive hit from the closure of cinemas because of the pandemic. Chinese theatres were able to reopen by midyear and have seen steady audience growth since then. Local movies have also benefited from periodic unofficial “blackout" periods, when only domestic productions are allowed to be screened. A dearth of major Hollywood blockbusters over recent months appears to have also boosted the market for Chinese films. “People were encouraged to stay in Beijing for the Lunar New Year, and so watching movies in the cinema became the top choice of entertainment,” said Chu Donglei, marketing manager at Poly Cinema’s Tiananmen branch in central Beijing. Mask wearing is mandatory and moviegoers must register with a cellphone app so they can be traced in the event of an outbreak. Only every other seat is allowed to be occupied, making it even harder to obtain tickets for the most popular films. According to the China Movie Data Information Network, 95% of ticket sales came from the seven top-grossing films timed for release around the Lunar New Year festival, which began this year on Feb. 12. “Hi, Mom,” a time-travelling comedy written and directed by and starring Jia Ling, was the top earner with 4.36 billion yuan, followed by action comedy “Detective Chinatown 3,” with 4.13 billion yuan. Wang Xiaoyu, 32, who works in the film industry, was only able to procure a ticket for “Hi, Mom” on Thursday and called the viewing experience “deeply moving." “I know there are some movies that are released and streamed online. But I think the experience of watching movies online is not as good as that of watching in a cinema,” Wang said. A lack of entertainment options helped pump up ticket sales during the pandemic, foretelling a bright future for the Chinese film industry, Wang said. Recent box office figures show the “great resiliency and powerful foundation of China’s film industry," said Fu Yalong, deputy general manager of the Solution Center at ENDATA, an analysis firm focusing on the entertainment industry. “During the Lunar New Year, there were films with a variety of genres and topics and the audiences were satisfied," Fu said. “Even with the impact of the pandemic and the increase in ticket prices, we were still able to score such achievements.” College student Zhang Jiazhi, 21, said the movie theatre experience was a welcome break from staying at home watching videos. Successful online film promotion also helped attract many viewers to brick-and-mortar cinemas, Zhang said. “I’m bored, and you can’t stay at home watching (streaming service) Douyin all the time, so I came to the cinema to watch a movie. There’s nothing to do,” said Zhang, who is on winter break and came to the cinema to see “A Writer’s Odyssey," a Chinese fantasy film which he said he didn’t quite understand. Last year, China sold an estimated $2.7 billion in tickets compared to $2.3 billion in the U.S., which saw an 80% drop in ticket sales. “The Eight Hundred," an action drama glorifying China's resistance to Japanese invaders in 1930s Shanghai, was the world's biggest hit, making $461.3 million at the box office, most of it within China. China's theatres also closed for a time during the height of COVID-19 in the country last spring, but gradually reopened over the summer. As of Friday, China has gone 11 days without reporting a single new case of local transmission of the virus. Since the outbreak was first detected in the central city of Wuhan in late 2019, China has reported a total of 89,877 cases, including 4,636 deaths. ___ Associated Press news assistant Caroline Chen contributed to this report. Andy Wong, The Associated Press
(Dan Taekema/CBC - image credit) Mayor Drew Dilkens says Windsor's chief of police has made the decision to provide naloxone to all officers. In an interview with CBC Radio's Windsor Morning Friday, Dilkens said the decision was connected to the opening of the aquatic centre as a shelter for COVID-19-positive people who are experiencing homelessness. The emergency shelter has 24-hour policing which is being carried out by officers from various units, not just the divisions that were previously equipped with the overdose-reversing drug. "So I know she's going to make the decision to arm all of the officers at Windsor Police Service with Naloxone, and we've always said this will be a data-driven decision and that these changes will happen as the facts change, and guess what — the facts are changing." Dilkens, who is chair of the Windsor's police services board, said chief Pam Mizuno is doing "the right thing." CBC News reached out to Windsor police for an interview, but Mizuno was did not provide comment. There is no information available from police about the cost or timing of the naloxone rollout. In October, CBC News looked at Windsor police reports that showed officers were first to respond to an opioid overdose in at least 14 cases over a 13 month span. This meant that officers had to sometimes wait for paramedics before naloxone could be administered. On one occasion, officers waited 39 minutes for paramedics to arrive at a scene and administer naloxone to a woman, who then became conscious and responsive. 'Unfortunate that it took this long' In recent months, calls for emergency responders to carry naloxone have mounted amid the opioid overdose crisis. Among those advocating for officers to carry the drug included president of the Windsor Police Association Shawn McCurdy. He told CBC News Friday that he's pleased with the decision. "It's unfortunate that it took this long, but the right decision has been made now," he said. "It's a peace of mind now that we have this tool with us that hopefully we don't ever have to use but if we do, it's there." The Windsor Police Service is one of the last major units in the province to get approval to carry naloxone, he said. Currently, Windsor police have officers with three units — detention, city centre patrol and problem-oriented policing — that had access to the drug. City council unanimously voted earlier this year to direct the fire service to start carrying naloxone nasal spray kits. Lisa Valente, a member of Families Stop the Harm, says police having naloxone is the difference between life and death for many who overdose on opioids. There were 29 emergency room visits related to opioid overdoses in Windsor-Essex last month alone, according to the Windsor-Essex County Health Unit. In 2019, 47 opioid overdose deaths in Windsor-Essex were reported by the Office of the Chief Coroner of Ontario. A member of a local harm reduction group, Family Stop the Harm, Lisa Valente said she was "happy" to hear the news, but notes that this was a long time coming. "I think it should have been approved a long time ago. We lost a lot of lives this year, we lost a lot of lives just in the past few weeks," she said. "The police having naloxone kits is the difference between living and dying ... When you call 911 police, ambulance, fire chances are police may be the first person there and if police have the kit and they have the opportunity to save somebody's life, that's huge... a lot of people are dying."
(Walter Strong/CBC - image credit) Justice Louise Charbonneau sentenced Tariq St Croix Thursday to five years in jail and three years probation for "brutally" stabbing his ex-wife on New Year's Eve two years ago. St Croix pleaded guilty to breaking and entering and aggravated assault in N.W.T. Supreme Court. The Crown prosecutor and defence lawyers jointly recommended a five-year sentence. "It is luck that St Croix isn't facing a homicide trial," Charbonneau told the courtroom. Tariq St. Croix, covering his face with a garment, has been charged with aggravated assault and breaking and entering. Tariq has one year, nine months, and one week remaining in his sentence. Upon his release, he is required to leave the N.W.T. On the evening of the attack, Marina St Croix was with her kids on their balcony waiting for fireworks to begin, when Tariq St Croix appeared outside of their residence. Tariq was on probation for previously assaulting her and was legally prohibited from visiting Marina unless she permitted him. Marina, who was pregnant at the time, told Tariq to go away, but he broke into the house by smashing a window, then armed himself with a steak knife. Marina was holding her 18-month-old infant in her bedroom when Tariq stabbed her in the face, neck and torso in the presence of her two kids. The eldest child grabbed the infant for protection. Tariq repeatedly yelled "you don't love me" before the steak knife broke, lodged in her stomach. Marina tried to flee to the balcony to call for help when Tariq dragged her back in, kicked her face, then fled. Marina asked that the publication ban on her name be lifted, as she no longer wanted the violence perpetrated against Indigenous women and children to be hidden from sight. Mistrust of the system Marina gave a victim impact statement before sentencing. With her sister standing next to her, and Tariq merely meters away, she described how the crime has changed her life. "On the Sunday before the week of my fate, I watched a video on highway 16. Trudeau's words were that Canada failed Indigenous women and that the MMIWG report would not be shelved. Yet, I stand ready to flee, when my only protection between him and me is three years probation." "We live in a society that would rather have my race live in a boat that no longer floats," she continued. "Life is easy for those who fail to see, so society covers their eyes with coins to let the violence breathe. "I see too many dead women and children that the RCMP fail to find. So I must admit I cannot trust the broken system, this time. "Welcome to court in Canada when you are Indigenous," Marina concluded. Marina said she cannot trust a broken legal system that fails to protect Indigenous women and children from their abusers. Justice Charbonneau told the court she "can understand that a court order would not appear adequate, given the crime took place when two probation orders were in force." Judge 'bound' by joint submission Tariq St Croix was initially charged with attempted murder in addition to the crime he was convicted of, but the greater charge was withdrawn when he pleaded guilty to breaking and entering and aggravated assault. In a previous court appearance, Charbonneau acknowledged that the five-year sentence was on the "very, very low end." Judges are bound by a Supreme Court of Canada ruling to accept joint submissions unless they can prove that the sentence is "unhinged" from the circumstances of the crime. "The question I have to answer is not to see if a five year sentence is fit," but if the sentence would break down the administration of justice, she said Thursday. Despite her reservations,Charbonneau said she was certain that Crown and the defense lawyers gave careful consideration to their submission. Deportation possible Tariq has one year, nine months and one week remaining in his sentence. Upon his release, he is required to leave the N.W.T. The court heard that Tariq had been the victim of an "extremely" violent upbringing. As a child growing up in St Lucia, his father had abused his mother repeatedly. Tariq's mother assaulted him and his siblings, which was described as torture at times. "Miraculously," Tariq has rekindled his relationship with his mother, the judge told the court. However, the circumstances of his difficult upbringing "cannot excuse the extreme violence of the crime," Charbonneau said. He is likely to face deportation, given the severity of the crime along with his existing criminal record. Originally from St Lucia, Tariq has permanent residency in Canada. He is qualified as a protected person, which means an additional step is required for deportation. Whether he will be deported depends on if the danger he poses in Canada outweighs the risk he may face if he returns to his home country. However, he is likely to lose permanent residency status.
Digital assets under management across exchange-traded products doubled this month to a record $43.9 billion, researcher CryptoCompare said on Friday, underscoring soaring interest in securities that track digital currencies. Bitcoin has leapt over 60% this year, hitting an all-time high of $58,354 this month as mainstream companies such as Tesla Inc and Mastercard Inc embraced cryptocurrencies. Still, daily trading volumes across all varieties of exchange-traded products involving cryptocurrencies slumped 38% in February from a month earlier to $936 million, CryptoCompare said in a research report.
(Lee Jin-man/The Associated Press - image credit) After a months-long review, Health Canada regulators today approved the COVID-19 vaccine from Oxford University-AstraZeneca for use in Canada — clearing the way for millions more inoculations in the months ahead. The department's regulators concluded the shot has an efficacy rate of 62 per cent and have authorized it for use in all adults 18 and older. While it's less effective than the Pfizer-BioNTech and Moderna vaccines at preventing infection, the shot is 100 per cent effective in preventing the severe outcomes of COVID-19 — including serious illness, hospitalizations and death — the regulators said. "Overall, there are no important safety concerns, and the vaccine was well tolerated by participants," the decision reads. Canada has secured access to 22 million doses of the AstraZeneca vaccine, most of which are slated to arrive between April and September. A nurse administers a dose of the Oxford-AstraZeneca COVID-19 vaccine in Goyang, South Korea, on Friday. Public Services and Procurement Minister Anita Anand has said the government is trying to negotiate faster delivery of these doses now that new, more contagious COVID-19 variants are taking hold in Canada. Health Canada also has authorized the vaccine manufactured by the Serum Institute, which has partnered with AstraZeneca to make that company's COVID-19 product at its facilities in India. That version, which is biologically identical to the AstraZeneca shot but is manufactured under different conditions, has been branded "Covishield." The Serum Institute, which is working with Mississauga, Ont.-based Verity Pharmaceuticals, will deliver 500,000 doses of its vaccine next Wednesday, the company told CBC News. A further 1 million doses will arrive in April and 500,000 more in early May. With these new doses, Canada now stands to receive about 6.5 million doses of the AstraZeneca, Moderna and Pfizer vaccines by the end of March. That's enough to fully vaccinate just over 3.2 million people. "This is very encouraging news. It means more people vaccinated, and sooner. Because for AstraZeneca, just like we were for Pfizer and Moderna, we are ready to get doses rolling," Prime Minister Justin Trudeau said. "Vaccines will keep arriving faster and faster as we head into the spring." WATCH: Anand says Canada will receive first batch of AstraZeneca in coming days Anand told reporters her department "will leave no stone unturned" in its quest to bring more doses into Canada "as quickly as possible." She said the government has received "positive indications" that the other AstraZeneca deliveries are on track but she could not say just how many shots will arrive in the second quarter. What is known is that at least 26.4 million more doses — 23 million from Moderna and Pfizer combined, 1.5 million AstraZeneca doses from the Serum Institute and another 1.9 million AstraZeneca doses from COVAX, the global vaccine-sharing initiative — will arrive between April and June. All told, the country is projected to have enough supply to fully vaccinate at least 16.45 million people by Canada Day. The supply will grow once delivery schedules for the AstraZeneca doses are confirmed. Canada is a vaccine laggard in the Western world right now; dozens of other countries have vaccinated more people per capita. The government has been insisting that everyone who wants a shot will get one by the end of September. Asked today if the new approval will result in an earlier end date for the vaccination campaign, Health Minister Patty Hajdu said she's hopeful but there could be more "bumps" and "unexpected challenges" that disrupt delivery schedules. Canada faced shortages earlier this year when Pfizer retooled its Belgian plant and Moderna slashed planned deliveries. 'Promising evidence' Some countries — such as France — have restricted the AstraZeneca vaccine to people under the age of 65, even though the World Health Organization insists the product is safe and effective for all age groups Health Canada said the clinical trial results "were too limited to allow a reliable estimate of vaccine efficacy in individuals 65 years of age and older," but the department was comfortable with approving the shot because of "post-market experience in regions where the vaccine has already been deployed." Speaking at a technical briefing today, Dr. Supriya Sharma, Health Canada's chief medical adviser, conceded there was limited clinical trial data about the efficacy of the shot in people over the age of 65 but said regulators approved it because of "promising evidence from real-world use of the vaccine." Other countries — notably Australia, the European Union and the United Kingdom — have authorized AstraZeneca already for use in their jurisdictions. WATCH | How the AstraZeneca COVID-19 vaccine has performed so far: In a study of vaccine efficacy in Scotland — where both the AstraZeneca and Pfizer products have been in widespread use for weeks — researchers found the AstraZeneca product reduced the risk of COVID-19 hospital admissions by roughly 94 per cent, 28 to 34 days after the first shot. The researchers also warned that the study sample was quite small. While there are risks associated with any vaccine, Sharma said, the benefits of getting an AstraZeneca shot "outweigh their potential risks." Sharma said it will be up to the National Advisory Committee on Immunization (NACI) to decide which groups should get each type of vaccine. And while the AstraZeneca product was found to be less effective than the Pfizer and Moderna shots already approved, Sharma said there's no doubt that a dose of this vaccine is better than no dose at all. Still better than the flu shot She cautioned Canadians against comparing efficacy rates of the various vaccine products, saying that in the areas that matter most — preventing serious illness, reducing hospitalizations and curbing the number of deaths — "all these vaccines are good." "If you look across all the clinical trials of the tens of thousands of people who were involved, the number of cases of people who died from COVID-19 that got vaccines was zero," Sharma said. "The number of people that were hospitalized because their COVID-19 disease was so severe was zero. The number of people that died because of an adverse event or effect of the vaccine was zero." She also noted that the AstraZeneca vaccine's efficacy rate is actually higher than that of other common vaccine products — including the flu shot. Flu vaccines, which differ each year depending on the flu strain in circulation, are typically 54 to 64 effective against seasonal influenza, Sharma said, and yet they are still widely used to offer some level of protection to more people. "I think Canada is hungry for vaccines. We're putting more on the buffet table to be used," she said. WATCH: Dr. Sharma outlines efficacy of AstraZeneca vaccine Health Canada is recommending that the second dose of the AstraZeneca product be administered four to 12 weeks after the first, but Sharma said there is early evidence suggesting it's best to wait the full 12 weeks to deploy the second shot. "With an increased interval, the efficacy might be much higher," she said. The product was approved in Australia, for example, but regulators there recommended a three-month wait between shots. Unlike the Moderna and Pfizer shots, which are based on groundbreaking mRNA technlogy, the AstraZeneca product uses a more conventional viral vector load vaccine platform. The AstraZeneca shot also doesn't require the same cold storage equipment necessary for the other two. The product can be stored and transported at normal refrigerated temperatures of 2 to 8 C for at least six months. This vaccine also can be easily administered in traditional health care settings, like a doctor's office or pharmacy. Regulator still reviewing 2 other vaccine candidates Health Canada is still reviewing two other vaccine candidates: one from Johnson & Johnson and another from Novavax. The U.S. Food and Drug Administration's vaccines advisory committee will meet today to review the clinical trial data for the Johnson & Johnson vaccine. A final U.S. decision on issuing emergency use authorization (EUA) could come as early as this weekend. Canada has ordered 10 million doses from Johnson & Johnson with options for up to 28 million more, if necessary. Most of those shots are expected to arrive by the end of September. While Health Canada regulators are aiming to make a decision on this product on a timeline similar to that of the FDA, Sharma said the department is still collecting some data from the manufacturer and a final decision is not expected this weekend.
A single voice could raise cash for health and art. The Raise Your Voice contest and virtual concert is a fundraiser focusing on both the Stevenson Memorial Hospital Foundation and the Gibson Centre. “We wanted to reach out to the community in this new safe world we’re living in and raise money for two very different causes,” said spokesperson Whitney Sallach. Sallach is urging amateur performers from Simcoe County to submit a song by March 14 before midnight for the June 3 virtual singing contest finale. Singers will be judged by Canadian musicians Marshall Dane Erin McCallum and Sophia Fracassi, who will also perform at the event. Contestants are asked to submit a sample of their singing, and assist the hospital and art centre by encouraging virtual concert ticket sales and the launch of the voting event. Three contestants will be chosen to sing at the virtual concert, and the grand prize winner will receive $1,000. Cheryl Browne, Local Journalism Initiative Reporter, Barrie Advance
WASHINGTON — Bouncing back from months of retrenchment, America's consumers stepped up their spending by a solid 2.4% in January in a sign that the economy may be making a tentative recovery from the pandemic recession. Friday’s report from the Commerce Department also showed that personal incomes, which provide the fuel for spending, jumped 10% last month, boosted by cash payments most Americans received from the government. The January spending increase followed two straight monthly spending drops that had raised concerns that consumers, who power most of the economy, were hunkered down, too anxious to travel, shop and spend. Last month's sharp gain suggests that many people are growing more confident about spending, especially after receiving $600 checks that went to most adults last month in a federal economic aid package. The government also reported Friday that inflation by a measure preferred by the Federal Reserve rose a moderate 0.3% in December. That left prices up 1.5% over the past 12 months, well below the Fed’s 2% target. Besides receiving cash payments, many Americans who have managed to keep their jobs have also been saving money for several months. That could bode well for the economy later this year, once consumers feel more willing to spend, vaccinations are more widely distributed and some version of President Joe Biden’s new economic aid proposal is enacted. Concerns that a strengthening economy will accelerate inflation have sent bond yields surging. On Thursday, the yield on the 10-year U.S. Treasury note moved above 1.5% — a level not seen in more than a year and far above the 0.92% it was trading at only two months ago. The move raised alarms on Wall Street and ignited a deep selloff in the stock market. Some investors fear that rising interest rates and the threat of inflation might lead the Fed to raise its benchmark short-term rate too quickly and potentially derail the economy. The tame inflation figure in Friday's report from the government shows that so far, price increases are mostly mild. In testimony to Congress this week, Fed Chair Jerome Powell downplayed the inflation risk and instead underscored the economy’s struggles. Layoffs are still high. And 10 million jobs remain lost to the pandemic that erupted nearly a year ago. That’s a deeper job loss than was inflicted by the Great Recession of 2008-2009. Still, despite the weakened job market, key sectors of the economy are showing signs of picking up as vaccinations increase and government rescue aid works its way through the economy. The Fed’s ultra-low-rate policy is providing important support as well. Retail sales soared last month. Factory output also rose and has nearly regained its pre-pandemic levels. And sales of newly built homes jumped in January. Martin Crutsinger, The Associated Press
From the United States to Germany and Australia, government borrowing costs on Friday were set to end February with their biggest monthly rises in years as expectations for a post-pandemic ignition of inflation gained a life of their own. Australia's 10-year bond yield and Britain's 30-year yields were set for their biggest monthly jump since the 2009 global financial crisis. Even after a Friday respite from this week's brutal drubbing, Australia's 10-year yield is up 70 basis points in February and New Zealand's 10-year yield is up almost 77 bps.
GameStop Corp closed 6% lower on Friday as an early rally fizzled but the stock finished the week 151% higher in a renewed surge that left analysts puzzled. Analysts have struggled to find a clear explanation, and some were skeptical the rally would have legs. Analysts mostly ruled out a short squeeze like the one that fueled GameStop's rally in January, when individual investors using Robinhood and other apps punished hedge funds that had bet against the stock, forcing them to unwind short positions.
Canada on Friday approved AstraZeneca's COVID-19 vaccine, including the version produced by the Serum Institute of India, and 500,000 doses are due to arrive next week. The vaccine is the third to be approved by Health Canada following the December approval of vaccines developed by Pfizer Inc with BioNTech SE and Moderna Inc. "With Pfizer, Moderna, and now AstraZeneca, Canada will get more than 6.5 million doses before the end of March," Prime Minister Justin Trudeau told reporters.
Protesters gathered in Tbilisi, Georgia over the arrest earlier in the week of opposition leader Nika Melia.View on euronews
LONDON — A woman who ran away from London as a teenager to join the Islamic State group lost her bid Friday to return to the U.K. to fight for the restoration of her citizenship, which was revoked on national security grounds. Shamima Begum was one of three east London schoolgirls who travelled to Syria in 2015. She resurfaced at a refugee camp in Syria and told reporters she wanted to come home, but was denied the chance after former Home Secretary Sajid Javid revoked her citizenship. Begum's lawyers appealed,, saying her right to a fair hearing was harmed by the obstacles of pursuing her case from the camp. The U.K. Supreme Court disagreed, ruling Friday that the right to a fair hearing does not trump all other considerations, such as public safety. “The appropriate response to the problem in the present case is for the deprivation hearing to be stayed - or postponed - until Ms. Begum is in a position to play an effective part in it without the safety of the public being compromised,'' said Justice Robert Reed, the president of the Supreme Court. “That is not a perfect solution, as it is not known how long it may be before that is possible. But there is no perfect solution to a dilemma of the present kind.” Javid argued that Begum was Bangladeshi by descent and could go there. She challenged the decision, arguing she is not a citizen of another country and that Javid’s decision left her stateless. The human rights group Liberty said the court’s ruling sets “an extremely dangerous precedent”. “The right to a fair trial is not something democratic governments should take away on a whim, and nor is someone’s British citizenship,'' said Rosie Brighouse, a lawyer with Liberty. “If a government is allowed to wield extreme powers like banishment without the basic safeguards of a fair tria,l it sets an extremely dangerous precedent.'' Danica Kirka, The Associated Press
BERLIN — A Bavarian radio station apologized Friday for a host's comments comparing popular South Korean K-pop band BTS to the coronavirus, saying his choice of words had gone too far but was in no way meant to be “hurtful or racist.” The statement came after legions of fans accused the station's Matthias Matuschik of racism for his comments on the band's cover of Coldplay's “Fix You,” taking to social media using the hashtags #Bayern3Racist, #Bayern3Apologize and #RassismusBeiBayern3 which translates as “racism at Bayern3.” “Racism is not an option,” wrote one user, @Vroseeeee1 in a blunt tweet in English, German, Korean and Spanish. The uproar came after a live show Wednesday, in which Matuschik derided BTS's version of “Fix You” as “blasphemy” and compared the band to COVID-19, describing them as “some crappy virus that hopefully there will be a vaccine for soon as well.” He then dug his hole deeper as he tried to roll back the comment somewhat, saying “I have nothing against South Korea, you can’t accuse me of xenophobia only because this boyband is from South Korea... I have a car from South Korea. I have the coolest car around.” Then he went on to say that in penance for the cover, BTS “will be vacationing in North Korea for the next 20 years.” BTS, which debuted in 2013, became the biggest boy band in the world, selling out stadiums worldwide and delivering a video message at the U.N. General Assembly this year. Their songs, filled with intimate, socially conscious lyrics, are credited for their success. Unlike other K-pop bands that carefully maintain the personas created by their labels, BTS is known for its active engagement with fans — known as ARMY — through social media. BTS has over 33.1 million followers on Twitter. Offence at the comments didn't only come from South Korea, with many social media users in Germany and elsewhere immediately condemning them. “I know which radio station I won't be listening to anymore, bye @Bayern3,” wrote user @fairesvmns in a German-language post that included audio of Matuschik's comments. “I really don't need racism of this shape and form in 2021.” Many South Koreans living abroad expressed concerns that the remarks could incite anti-Asian violence, already on the rise in many places. “This is not just about #BTS, it is about so many Asian people who are dealing with extreme racism especially due to pandemic,” Hansl Chang, a South Korean who lives in Germany, tweeted. In the station's apology, it said that while Matuschik was “presenting his opinion in an ironic, exaggerated way and with exaggerated excitement, his words went too far and hurt the feelings of BTS fans. “But he — and he has assured us of this — in no way intended this. He just wanted to express his displeasure over the aforementioned cover version.” It noted that Matuschik has been involved in helping raise aid for refugees and has a “constant campaign against right-wing extremism” and has shown he is against xenophobia or racism in any form. “That does not change the fact that many of you found his statements to be hurtful or racist,” Bayern3 said. “We apologize for this in every way possible. We will work on the matter with Matthias and the team in detail again in the next few days.” ___ Juwon Park in Seoul, South Korea, contributed to this report. David Rising, The Associated Press
Court found government was entitled to use an emergency law to introduce the measures forcing residents indoors from 9 pm to 4:30 amView on euronews